Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mult-OiL Fat Emulsion Injection
- Development stage
- Unknown
- Lead developer
- Fresenius Kabi
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
Mult-OiL Fat Emulsion Injection (C6–24) is a multi-component lipid emulsion developed by Sichuan Kelun Pharmaceutical and Chengdu Goworld Pharmaceutical for parenteral nutrition. It is a 'four-oil' emulsion typically composed of soybean oil, medium-chain triglycerides (MCT), olive oil, and fish oil, covering a fatty acid carbon chain range of C6 to C24. This formulation is designed to provide a comprehensive lipid profile: soybean oil provides essential omega-6 fatty acids; MCTs offer a rapidly available energy source; olive oil provides monounsaturated omega-9 fatty acids for oxidative stability; and fish oil provides omega-3 fatty acids (EPA and DHA) which may exert anti-inflammatory effects. The drug is currently in Phase 3 clinical trials in China for the treatment of postoperative nutritional deficiency in patients undergoing elective abdominal surgery who require total parenteral nutrition.
- Brand names
- Mult-OiL
- Other names
- Mult-OiL Fat Emulsion Injection (C6–24)多油脂肪乳注射液(C6~24)
Beyond the preview
Go deeper on Mult-OiL Fat Emulsion Injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mult-OiL Fat Emulsion Injection.